Cerity Partners
VNRX icon

Cerity Partners’s VolitionRx Ltd VNRX Stock Holding History

Cerity Partners’s Portfolio VNRX Stock Details VNRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-3,250
Closed -$124K – 1964
2023
Q1 		$124K Buy
3,250
+1,349
+71% +$56.5K ﹤0.01% 1758
2022
Q4 		$92.4K Buy
+1,901
New +$73.8K ﹤0.01% 1412

Other funds holding VNRX

LIM
Lagoda Investment Management New York $162M AUM 49.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CPA
Cowen Prime Advisors New York $290M AUM 57.8% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
SAMC
Spectrum Asset Management (California) Newport Beach, California $315M AUM 19.93% 1-Year Est. Return

Cerity Partners's VNRX Position: Q2 2023 in Review

Cerity Partners sold out of VolitionRx Ltd (VNRX) in Q2 2023, closing a stake of 3,250 shares — an estimated $124K sold.

Cerity Partners first reported a position in VNRX in Q4 2022 and held it in 2 quarters. The position peaked at $124K in Q1 2023. 34 funds tracked by Wall St. Rank hold VNRX as of Q2 2023.

  • Cerity Partners reported no remaining VolitionRx Ltd position as of Q2 2023 after selling out during the quarter.
  • Cerity Partners sold 3,250 VolitionRx Ltd shares in Q2 2023, an estimated $124K.
  • Cerity Partners first reported a position in VolitionRx Ltd in Q4 2022 and held it in 2 quarters.
  • Cerity Partners's VolitionRx Ltd position peaked at $124K in Q1 2023.
  • 34 funds tracked by Wall St. Rank held VolitionRx Ltd as of Q2 2023.

Based on Cerity Partners's 13F filing for Q2 2023, filed 14 Aug 2023.